The increased secretion of IL-6 by MUC2-knockdown tumor cells and enhanced tumor growth observed in the present study suggest that the protective mechanisms of MUC2 in colon cancer may be associated with its effects on suppressing the IL-6/STAT3 signaling pathway. This evidence concerns the gene STAT3 and colonic neoplasm.